Advertisement

Topics

Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M

12:34 EST 17 Jan 2019 | MedCity News

CEO Joe Turgeon said in an interview that the company aims to focus more on developing drugs for larger, broader and more lucrative oncology markets.

Original Article: Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M

NEXT ARTICLE

More From BioPortfolio on "Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...